Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Sol-Gel initiates phase I study of SGT-210 in punctate palmoplantar keratoderma

Jan. 3, 2020

Taiwan FDA approves Lumosa's IND for LT-5001 for uremic pruritus

Jan. 3, 2020

Novan reports topline efficacy data from phase III B-SIMPLE program of SB-206 for molluscum

Jan. 3, 2020

Durect discontinues development of DUR-928 for psoriasis

Jan. 3, 2020

Principia advances PRN-1008 for pemphigus with accelerated enrollment in phase III study

Dec. 31, 2019

Topline data presented from E.U. phase III study of Wynzora Cream for psoriasis vulgaris

Dec. 20, 2019

Topline data reported from phase II study of ARQ-151 in atopic dermatitis

Dec. 18, 2019

Ustekinumab biosimilar DMB-3115 begins phase I trial

Dec. 16, 2019

Decoding EGFR's skin toxicity

Dec. 16, 2019

Three phase III trials of tralokinumab in atopic dermatitis meet endpoints

Dec. 11, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...